A detailed history of Barclays PLC transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 649,773 shares of ZBH stock, worth $71.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
649,773
Previous 649,773 -0.0%
Holding current value
$71.6 Million
Previous $70.1 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$104.47 - $116.17 $5.39 Million - $5.99 Million
-51,587 Reduced 7.36%
649,773 $70.1 Million
Q2 2024

Aug 14, 2024

SELL
$106.25 - $130.01 $1.85 Million - $2.26 Million
-17,372 Reduced 2.42%
701,360 $76.1 Million
Q1 2024

May 15, 2024

BUY
$119.98 - $132.61 $1.22 Million - $1.35 Million
10,146 Added 1.43%
718,732 $94.9 Million
Q4 2023

Feb 15, 2024

SELL
$102.72 - $121.7 $37.4 Million - $44.3 Million
-363,908 Reduced 33.93%
708,586 $86.2 Million
Q3 2023

Nov 07, 2023

BUY
$110.76 - $143.18 $67 Million - $86.6 Million
604,652 Added 129.24%
1,072,494 $120 Million
Q2 2023

Aug 03, 2023

BUY
$126.43 - $145.6 $27.9 Million - $32.1 Million
220,328 Added 89.02%
467,842 $68.1 Million
Q1 2023

May 04, 2023

SELL
$121.91 - $130.94 $8.49 Million - $9.12 Million
-69,680 Reduced 21.97%
247,514 $32 Million
Q4 2022

Feb 13, 2023

BUY
$104.7 - $128.4 $4.85 Million - $5.95 Million
46,366 Added 17.12%
317,194 $40.4 Million
Q3 2022

Nov 03, 2022

BUY
$101.65 - $119.27 $5.38 Million - $6.32 Million
52,971 Added 24.31%
270,828 $28.3 Million
Q2 2022

Aug 12, 2022

SELL
$102.23 - $133.85 $28.2 Million - $36.9 Million
-275,926 Reduced 55.88%
217,857 $22.9 Million
Q1 2022

May 16, 2022

SELL
$108.42 - $129.58 $14.8 Million - $17.7 Million
-136,215 Reduced 21.62%
493,783 $63.2 Million
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $128,358 - $163,052
1,112 Added 0.18%
629,998 $80 Million
Q3 2021

Nov 09, 2021

BUY
$136.35 - $158.76 $6.87 Million - $8 Million
50,362 Added 8.71%
628,886 $92 Million
Q2 2021

Aug 13, 2021

BUY
$152.95 - $173.41 $1.67 Million - $1.89 Million
10,897 Added 1.92%
578,524 $93 Million
Q1 2021

May 13, 2021

BUY
$148.16 - $159.71 $16.4 Million - $17.7 Million
110,624 Added 24.21%
567,627 $90.9 Million
Q4 2020

Feb 11, 2021

BUY
$128.25 - $151.41 $4.19 Million - $4.95 Million
32,676 Added 7.7%
457,003 $70.4 Million
Q3 2020

Nov 12, 2020

BUY
$113.59 - $141.68 $3.62 Million - $4.52 Million
31,891 Added 8.13%
424,327 $57.8 Million
Q2 2020

Aug 12, 2020

SELL
$87.02 - $133.4 $1.01 Million - $1.55 Million
-11,647 Reduced 2.88%
392,436 $46.8 Million
Q1 2020

May 13, 2020

SELL
$78.28 - $155.73 $16.4 Million - $32.6 Million
-209,104 Reduced 34.1%
404,083 $40.8 Million
Q4 2019

Feb 10, 2020

SELL
$127.4 - $146.83 $8.79 Million - $10.1 Million
-69,031 Reduced 10.12%
613,187 $91.8 Million
Q3 2019

Nov 14, 2019

SELL
$113.33 - $138.46 $23.8 Million - $29.1 Million
-209,948 Reduced 23.53%
682,218 $93.7 Million
Q2 2019

Aug 14, 2019

BUY
$108.87 - $125.09 $3.53 Million - $4.06 Million
32,449 Added 3.77%
892,166 $105 Million
Q1 2019

May 15, 2019

BUY
$97.5 - $125.79 $14.5 Million - $18.7 Million
148,853 Added 20.94%
859,717 $110 Million
Q4 2018

Feb 14, 2019

SELL
$94.4 - $126.76 $3.87 Million - $5.2 Million
-41,028 Reduced 5.46%
710,864 $73.7 Million
Q3 2018

Nov 14, 2018

BUY
$108.41 - $127.64 $4.87 Million - $5.73 Million
44,918 Added 6.35%
751,892 $98.9 Million
Q2 2018

Aug 14, 2018

SELL
$102.12 - $114.04 $13.9 Million - $15.6 Million
-136,584 Reduced 16.19%
706,974 $78.8 Million
Q1 2018

May 15, 2018

BUY
$104.31 - $124.46 $23.5 Million - $28.1 Million
225,380 Added 36.46%
843,558 $92 Million
Q4 2017

Feb 14, 2018

BUY
$105.55 - $120.83 $18 Million - $20.6 Million
170,866 Added 38.2%
618,178 $74.6 Million
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $47.8 Million - $52.7 Million
447,312
447,312 $52.4 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.